Vesnarinone
From Self-sufficiency
| File:Vesnarinone.png | |
| Systematic (IUPAC) name | |
|---|---|
|
6-[4-(3,4-dimethoxybenzoyl)piperazin-1-yl]-3,4-dihydro-1H-quinolin-2-one | |
| Clinical data | |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 81840-15-5 |
| ATC code | none |
| PubChem | CID 5663 |
| Chemical data | |
| Formula | C22H25N3O4 |
| Molar mass | 395.45 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Vesnarinone (INN) is a cardiotonic agent. A mixed phosphodiesterase 3 inhibitor and ion-channel modifier that has modest, dose-dependent, positive inotropic activity, but minimal negative chronotropic activity. Vesnarinone improves ventricular performance most in patients with the worst degree of heart failure.
| 30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- 2Fix
- Phosphodiesterase inhibitors
- Piperazines
- Quinolines
- Lactams
- Amides
- Phenol ethers
- Cardiovascular system drug stubs
